What is the initial test for diagnosing Cushing syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Testing for Cushing Syndrome

The overnight 1-mg Dexamethasone Suppression Test (DST) is recommended as the initial screening test for diagnosing Cushing syndrome, according to the Endocrine Society guidelines. 1

First-Line Diagnostic Tests

The Endocrine Society recommends the following initial tests for screening patients with suspected Cushing syndrome:

  1. Overnight 1-mg Dexamethasone Suppression Test (DST)

    • Procedure: 1 mg dexamethasone administered at 11 PM, with cortisol measured at 8 AM the next day
    • Interpretation: Failure to suppress morning cortisol suggests Cushing syndrome
    • Best used for: Initial screening, evaluation of adrenal incidentalomas, and patients with disrupted circadian rhythms 1
  2. Late-Night Salivary Cortisol (LNSC)

    • Sensitivity: >90%, Specificity: 100%
    • Particularly useful for: Initial screening and longitudinal surveillance of cyclic Cushing syndrome 1
  3. 24-hour Urinary Free Cortisol (UFC)

    • Used to support diagnosis and reflect overall cortisol production 1

Test Selection Algorithm

  1. Start with overnight 1-mg DST as the initial screening test
  2. Consider adding LNSC if there is suspicion of cyclic Cushing syndrome
  3. Use 24-hour UFC as a supporting diagnostic test
  4. Measure plasma ACTH to differentiate between ACTH-dependent and ACTH-independent causes once hypercortisolism is confirmed 1

Important Considerations and Pitfalls

  • Test Limitations: The standard 1-mg overnight DST may have reduced sensitivity in patients with mild and/or episodic hypercortisolism. Studies have shown that many patients with mild Cushing syndrome can suppress to overnight dexamethasone, potentially leading to false negatives 2

  • Improved Specificity: Measuring serum dexamethasone levels simultaneously with cortisol can improve test specificity. The lower limit of normal for dexamethasone is 1.8 ng/mL 1

  • Alternative Approaches: Some research suggests that a lower dose (0.5 mg) DST may provide better sensitivity and specificity (99.1% and 98.4% respectively) with a cortisol cut-off of 3.05 μg/dL 3

  • Medication Interference: Women on estrogen-containing oral contraceptives may have false positive results when undergoing the 1-mg DST due to estrogen's effect on dexamethasone metabolism 1

  • Pediatric Considerations: In children, Cushing's disease accounts for 75-80% of cases in those over age 6, while adrenal causes are more common in younger children. Unexplained weight gain combined with growth failure is a key indicator 1

Next Steps After Initial Testing

If the initial screening test is positive:

  1. Confirm hypercortisolism with additional tests (LNSC or 24-hour UFC)
  2. Measure plasma ACTH to differentiate between ACTH-dependent and ACTH-independent causes
  3. Proceed with appropriate imaging studies based on ACTH status
  4. Consider bilateral inferior petrosal sinus sampling (IPSS) for ACTH-dependent cases with equivocal results 1

Remember that no single test is perfect for diagnosing Cushing syndrome, especially in mild or cyclic cases. The overnight 1-mg DST remains the recommended initial test, but clinicians should maintain a high index of suspicion and follow up with additional testing when clinical features strongly suggest Cushing syndrome despite a negative initial test.

References

Guideline

Diagnosis and Management of Endogenous Hypercortisolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An update on the overnight dexamethasone suppression test for the diagnosis of Cushing's syndrome: limitations in patients with mild and/or episodic hypercortisolism.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.